Nucleai
PrivateLast Round
VC Round
Apr 3, 2024
Total Funding Raised
$44.5M
Momentum Score
50 /100
Company Overview
Nucleai is a biotechnology company that offers a spatial biology software platform designed to enhance precision medicine through advanced artificial intelligence and machine learning technologies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nucleai Comps
Public and private peers based on sector, stage, and business model.
Nucleai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 3, 2024 | ||||
| Series B | Mar 22, 2022 | ||||
| Series A | Jul 7, 2020 | ||||
| Seed | Mar 5, 2018 |
Key People
Founding team and executive leadership
Nucleai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | VC Round, Series B |
| Grove Ventures | Series A, VC Round, Series B, Seed |
| Vvc Advisors | Series B |
| Fosun International | Series B |
| Vertex Ventures Israel | Series A, Seed |
| Sanofi Ventures | VC Round, Series B |
| Vertex Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Integrated spatial proteomics solution for drug development.
- Apr 15, 2026
Integrated spatial proteomics solution launched with Sirona Dx.
Nucleai Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nucleai's valuation, stock price, and market status.
